Clinical trial NCT03098407 - References

Pregnancy — Opioid Dependence Treatment Therapies in Pregnancy

Citation(s)

•   Almario CV, Seligman NS, Dysart KC, Berghella V, Baxter JK
  Risk factors for preterm birth among opiate-addicted gravid women in a methadone treatment program. Am J Obstet Gynecol. 2009 Sep;201(3):326.e1-6. doi: 10.1016/j.ajog.2009.05.052. Epub 2009 Jul 24.
•   Andersen R, Chen MS, Aday LA, Cornelius L
  Health status and medical care utilization. Health Aff (Millwood). 1987 Spring;6(1):136-56.
•   Ashley OS, Marsden ME, Brady TM
  Effectiveness of substance abuse treatment programming for women: a review. Am J Drug Alcohol Abuse. 2003;29(1):19-53. Review.
•   Bandstra ES, Morrow CE, Mansoor E, Accornero VH
  Prenatal drug exposure: infant and toddler outcomes. J Addict Dis. 2010 Apr;29(2):245-58. doi: 10.1080/10550881003684871. Review.
•   Barry DT, Irwin KS, Jones ES, Becker WC, Tetrault JM, Sullivan LE, Hansen H, O'Connor PG, Schottenfeld RS, Fiellin DA
  Integrating buprenorphine treatment into office-based practice: a qualitative study. J Gen Intern Med. 2009 Feb;24(2):218-25. doi: 10.1007/s11606-008-0881-9. Epub 2008 Dec 17.
•   Benningfield MM, Arria AM, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Fischer G, Jones HE, Martin PR
  Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women. Am J Addict. 2010 Sep-Oct;19(5):416-21. doi: 10.1111/j.1521-0391.2010.00064.x.
•   Benoit E, Young R, Magura S, Staines GL
  The impact of welfare reform on methadone treatment: policy lessons from service providers in New York city. Subst Use Misuse. 2004;39(13-14):2355-90.
•   Binder T, Vavrinková B
  Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department. Neuro Endocrinol Lett. 2008 Feb;29(1):80-6.
•   Burns L, Conroy E, Mattick RP
  Infant mortality among women on a methadone program during pregnancy. Drug Alcohol Rev. 2010 Sep;29(5):551-6. doi: 10.1111/j.1465-3362.2010.00176.x.
•   Chatham LR, Hiller ML, Rowan-Szal GA, Joe GW, Simpson DD
  Gender differences at admission and follow-up in a sample of methadone maintenance clients. Subst Use Misuse. 1999 Jun;34(8):1137-65.
•   Chisolm MS, Tuten M, Brigham EC, Strain EC, Jones HE
  Relationship between cigarette use and mood/anxiety disorders among pregnant methadone-maintained patients. Am J Addict. 2009 Sep-Oct;18(5):422-9. doi: 10.3109/10550490903077721.
•   Cleary BJ, Donnelly JM, Strawbridge JD, Gallagher PJ, Fahey T, White MJ, Murphy DJ
  Methadone and perinatal outcomes: a retrospective cohort study. Am J Obstet Gynecol. 2011 Feb;204(2):139.e1-9. doi: 10.1016/j.ajog.2010.10.004. Epub 2010 Dec 8.
•   Creanga AA, Sabel JC, Ko JY, Wasserman CR, Shapiro-Mendoza CK, Taylor P, Barfield W, Cawthon L, Paulozzi LJ
  Maternal drug use and its effect on neonates: a population-based study in Washington State. Obstet Gynecol. 2012 May;119(5):924-33. doi: 10.1097/AOG.0b013e31824ea276.
•   Dashe JS, Jackson GL, Olscher DA, Zane EH, Wendel GD Jr
  Opioid detoxification in pregnancy. Obstet Gynecol. 1998 Nov;92(5):854-8.
•   Deverka PA, Lavallee DC, Desai PJ, Esmail LC, Ramsey SD, Veenstra DL, Tunis SR
  Stakeholder participation in comparative effectiveness research: defining a framework for effective engagement. J Comp Eff Res. 2012 Mar;1(2):181-194.
•   Etter JF
  A comparison of the content-, construct- and predictive validity of the cigarette dependence scale and the Fagerström test for nicotine dependence. Drug Alcohol Depend. 2005 Mar 7;77(3):259-68.
•   Feske U, Tarter RE, Kirisci L, Pilkonis PA
  Borderline personality and substance use in women. Am J Addict. 2006 Mar-Apr;15(2):131-7.
•   Fiellin DA, Kleber H, Trumble-Hejduk JG, McLellan AT, Kosten TR
  Consensus statement on office-based treatment of opioid dependence using buprenorphine. J Subst Abuse Treat. 2004 Sep;27(2):153-9. Review.
•   Fiellin DA, Schottenfeld RS, Cutter CJ, Moore BA, Barry DT, O'Connor PG
  Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial. JAMA Intern Med. 2014 Dec;174(12):1947-54. doi: 10.1001/jamainternmed.2014.5302.
•   Fiellin DA
  The first three years of buprenorphine in the United States: experience to date and future directions. J Addict Med. 2007 Jun;1(2):62-7. doi: 10.1097/ADM.0b013e3180473c11.
•   Fischer G, Gombas W, Eder H, Jagsch R, Peternell A, Stühlinger G, Pezawas L, Aschauer HN, Kasper S
  Buprenorphine versus methadone maintenance for the treatment of opioid dependence. Addiction. 1999 Sep;94(9):1337-47.
•   Fischer G, Ortner R, Rohrmeister K, Jagsch R, Baewert A, Langer M, Aschauer H
  Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction. 2006 Feb;101(2):275-81.
•   Goodman D
  Buprenorphine for the treatment of perinatal opioid dependence: pharmacology and implications for antepartum, intrapartum, and postpartum care. J Midwifery Womens Health. 2011 May-Jun;56(3):240-7. doi: 10.1111/j.1542-2011.2011.00049.x. Review.
•   Hansen HB, Siegel CE, Case BG, Bertollo DN, DiRocco D, Galanter M
  Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City. J Behav Health Serv Res. 2013 Jul;40(3):367-77. doi: 10.1007/s11414-013-9341-3.
•   Holbrook AM, Jones HE, Heil SH, Martin PR, Stine SM, Fischer G, Coyle MG, Kaltenbach K
  Induction of pregnant women onto opioid-agonist maintenance medication: an analysis of withdrawal symptoms and study retention. Drug Alcohol Depend. 2013 Sep 1;132(1-2):329-34. doi: 10.1016/j.drugalcdep.2013.02.031. Epub 2013 Mar 21.
•   Jones ES, Fiellin DA
  Women and opioid dependence treatment: office-based versus opioid treatment program-based care? Subst Abus. 2007 Jun;28(2):3-8. doi: 10.1300/J465v28n02_02.
•   Jones ES, Moore BA, Sindelar JL, O'Connor PG, Schottenfeld RS, Fiellin DA
  Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients. Drug Alcohol Depend. 2009 Jan 1;99(1-3):132-40. doi: 10.1016/j.drugalcdep.2008.07.013. Epub 2008 Sep 19.
•   Jones HE, Deppen K, Hudak ML, Leffert L, McClelland C, Sahin L, Starer J, Terplan M, Thorp JM Jr, Walsh J, Creanga AA
  Clinical care for opioid-using pregnant and postpartum women: the role of obstetric providers. Am J Obstet Gynecol. 2014 Apr;210(4):302-310. doi: 10.1016/j.ajog.2013.10.010. Epub 2013 Oct 10.
•   Jones HE, Finnegan LP, Kaltenbach K
  Methadone and buprenorphine for the management of opioid dependence in pregnancy. Drugs. 2012 Apr 16;72(6):747-57. doi: 10.2165/11632820-000000000-00000. Review.
•   Jones HE, Heil SH, Baewert A, Arria AM, Kaltenbach K, Martin PR, Coyle MG, Selby P, Stine SM, Fischer G
  Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review. Addiction. 2012 Nov;107 Suppl 1:5-27. doi: 10.1111/j.1360-0443.2012.04035.x. Review.
•   Jones HE, Heil SH, O'Grady KE, Martin PR, Kaltenbach K, Coyle MG, Stine SM, Selby P, Arria AM, Fischer G
  Smoking in pregnant women screened for an opioid agonist medication study compared to related pregnant and non-pregnant patient samples. Am J Drug Alcohol Abuse. 2009;35(5):375-80. doi: 10.1080/00952990903125235.
•   Jones HE, Johnson RE, Jasinski DR, O'Grady KE, Chisholm CA, Choo RE, Crocetti M, Dudas R, Harrow C, Huestis MA, Jansson LM, Lantz M, Lester BM, Milio L
  Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend. 2005 Jul;79(1):1-10.
•   Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O'Grady KE, Selby P, Martin PR, Fischer G
  Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010 Dec 9;363(24):2320-31. doi: 10.1056/NEJMoa1005359.
•   Keegan J, Parva M, Finnegan M, Gerson A, Belden M
  Addiction in pregnancy. J Addict Dis. 2010 Apr;29(2):175-91. doi: 10.1080/10550881003684723.
•   Korthuis PT, Gregg J, Rogers WE, McCarty D, Nicolaidis C, Boverman J
  Patients' Reasons for Choosing Office-based Buprenorphine: Preference for Patient-Centered Care. J Addict Med. 2010 Dec;4(4):204-10. doi: 10.1097/ADM.0b013e3181cc9610.
•   Krans EE, Cochran G, Bogen DL
  Caring for Opioid-dependent Pregnant Women: Prenatal and Postpartum Care Considerations. Clin Obstet Gynecol. 2015 Jun;58(2):370-9. doi: 10.1097/GRF.0000000000000098.
•   Krans EE, Davis MM, Palladino CL
  Disparate patterns of prenatal care utilization stratified by medical and psychosocial risk. Matern Child Health J. 2013 May;17(4):639-45. doi: 10.1007/s10995-012-1040-9.
•   Krans EE, Davis MM, Schwarz EB
  Psychosocial risk, prenatal counseling and maternal behavior: findings from PRAMS, 2004-2008. Am J Obstet Gynecol. 2013 Feb;208(2):141.e1-7. doi: 10.1016/j.ajog.2012.11.017. Epub 2012 Nov 15.
•   Krans EE, Davis MM
  Preventing Low Birthweight: 25 years, prenatal risk, and the failure to reinvent prenatal care. Am J Obstet Gynecol. 2012 May;206(5):398-403. doi: 10.1016/j.ajog.2011.06.082. Epub 2011 Jun 29.
•   Krans EE, Moloci NM, Housey MT, Davis MM
  Impact of psychosocial risk factors on prenatal care delivery: a national provider survey. Matern Child Health J. 2014 Dec;18(10):2362-70. doi: 10.1007/s10995-014-1476-1.
•   Lacroix I, Berrebi A, Garipuy D, Schmitt L, Hammou Y, Chaumerliac C, Lapeyre-Mestre M, Montastruc JL, Damase-Michel C
  Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study. Eur J Clin Pharmacol. 2011 Oct;67(10):1053-9. doi: 10.1007/s00228-011-1049-9. Epub 2011 May 3.
•   Latt NC, Spencer JD, Beeby PJ, McCaughan GW, Saunders JB, Collins E, Cossart YE
  Hepatitis C in injecting drug-using women during and after pregnancy. J Gastroenterol Hepatol. 2000 Feb;15(2):175-81.
•   Madden JD, Chappel JN, Zuspan F, Gumpel J, Mejia A, Davis R
  Observation and treatment of neonatal narcotic withdrawal. Am J Obstet Gynecol. 1977 Jan 15;127(2):199-201.
•   Mattick RP, Kimber J, Breen C, Davoli M
  Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD002207. doi: 10.1002/14651858.CD002207.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;2:CD002207.
•   McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M
  The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat. 1992;9(3):199-213.
•   Meyer MC, Johnston AM, Crocker AM, Heil SH
  Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study. J Addict Med. 2015 Mar-Apr;9(2):81-6. doi: 10.1097/ADM.0000000000000092.
•   Moore BA, Fiellin DA, Barry DT, Sullivan LE, Chawarski MC, O'Connor PG, Schottenfeld RS
  Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients. J Gen Intern Med. 2007 Apr;22(4):527-30.
•   Morgenstern J, Hogue A, Dauber S, Dasaro C, McKay JR
  A practical clinical trial of coordinated care management to treat substance use disorders among public assistance beneficiaries. J Consult Clin Psychol. 2009 Apr;77(2):257-69. doi: 10.1037/a0014489.
•   Nunn A, Zaller N, Dickman S, Trimbur C, Nijhawan A, Rich JD
  Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend. 2009 Nov 1;105(1-2):83-8. doi: 10.1016/j.drugalcdep.2009.06.015. Epub 2009 Jul 21. Erratum in: Drug Alcohol Depend. 2011 Jan 15;113(2-3):252.
•   Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM
  Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA. 2012 May 9;307(18):1934-40. doi: 10.1001/jama.2012.3951. Epub 2012 Apr 30.
•   Peles E, Schreiber S, Naumovsky Y, Adelson M
  Depression in methadone maintenance treatment patients: rate and risk factors. J Affect Disord. 2007 Apr;99(1-3):213-20. Epub 2006 Oct 19.
•   Potter JS, Marino EN, Hillhouse MP, Nielsen S, Wiest K, Canamar CP, Martin JA, Ang A, Baker R, Saxon AJ, Ling W
  Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START). J Stud Alcohol Drugs. 2013 Jul;74(4):605-13.
•   Roman PM, Abraham AJ, Rothrauff TC, Knudsen HK
  A longitudinal study of organizational formation, innovation adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat. 2010 Jun;38 Suppl 1:S44-52. doi: 10.1016/j.jsat.2009.12.008.
•   Rowan-Szal GA, Chatham LR, Joe GW, Simpson DD
  Services provided during methadone treatment. A gender comparison. J Subst Abuse Treat. 2000 Jul;19(1):7-14.
•   Simpson DD
  A conceptual framework for drug treatment process and outcomes. J Subst Abuse Treat. 2004 Sep;27(2):99-121.
•   Stewart RD, Nelson DB, Adhikari EH, McIntire DD, Roberts SW, Dashe JS, Sheffield JS
  The obstetrical and neonatal impact of maternal opioid detoxification in pregnancy. Am J Obstet Gynecol. 2013 Sep;209(3):267.e1-5. doi: 10.1016/j.ajog.2013.05.026. Epub 2013 May 29.
•   Stine SM, Heil SH, Kaltenbach K, Martin PR, Coyle MG, Fischer G, Arria AM, Selby P, Jones HE
  Characteristics of opioid-using pregnant women who accept or refuse participation in a clinical trial: screening results from the MOTHER study. Am J Drug Alcohol Abuse. 2009;35(6):429-33. doi: 10.3109/00952990903374080.
•   Teruya C, Schwartz RP, Mitchell SG, Hasson AL, Thomas C, Buoncristiani SH, Hser YI, Wiest K, Cohen AJ, Glick N, Jacobs P, McLaughlin P, Ling W
  Patient perspectives on buprenorphine/naloxone: a qualitative study of retention during the starting treatment with agonist replacement therapies (START) study. J Psychoactive Drugs. 2014 Nov-Dec;46(5):412-26. doi: 10.1080/02791072.2014.921743.
•   Tuten M, Heil SH, O'Grady KE, Fitzsimons H, Chisolm MS, Jones HE
  The impact of mood disorders on the delivery and neonatal outcomes of methadone-maintained pregnant patients. Am J Drug Alcohol Abuse. 2009;35(5):358-63. doi: 10.1080/00952990903108231. Erratum in: Am J Drug Alcohol Abuse. 2010 Sep;36(5):304.
•   Whitley SD, Sohler NL, Kunins HV, Giovanniello A, Li X, Sacajiu G, Cunningham CO
  Factors associated with complicated buprenorphine inductions. J Subst Abuse Treat. 2010 Jul;39(1):51-7. doi: 10.1016/j.jsat.2010.04.001.
•   Winhusen T, Wilder C, Wexelblatt SL, Theobald J, Hall ES, Lewis D, Van Hook J, Marcotte M
  Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome. Contemp Clin Trials. 2014 Sep;39(1):158-65. doi: 10.1016/j.cct.2014.08.009. Epub 2014 Aug 23.

A Pilot Randomized Comparative Effectiveness Clinical Trial of Buprenorphine vs. Methadone for the Treatment of Opioid Dependence in Pregnancy.

Details for clinical trial NCT03098407